* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID Gene_Symbol DisGeNet_diseaseID Disease_name DisGeNet score DisGeNet_sourceDB
3206HOXA10C0014170Endometrial Neoplasms0.202732912464814CTD_human;LHGDN
3206HOXA10C0001418Adenocarcinoma0.200824180352639BEFREE;CTD_human
3206HOXA10C1720887Female Urogenital Diseases0.2CTD_human
3206HOXA10C0014175Endometriosis0.0171336962042138BEFREE;GAD;LHGDN
3206HOXA10C0023467Leukemia, Myelocytic, Acute0.00493072673851855BEFREE;LHGDN
3206HOXA10C0032460Polycystic Ovary Syndrome0.00300763924902685BEFREE;LHGDN
3206HOXA10C0023473Myeloid Leukemia, Chronic0.00300763924902685BEFREE;LHGDN
3206HOXA10C0010417Cryptorchidism0.0026817553075011BEFREE;GAD
3206HOXA10C0009081Congenital clubfoot0.002407028523288GAD
3206HOXA10C0023418leukemia0.0013736339210655BEFREE
3206HOXA10C0029925Ovarian Carcinoma0.0010989071368524BEFREE
3206HOXA10C0678222Breast Carcinoma0.0008241803526393BEFREE
3206HOXA10C0598766Leukemogenesis0.0008241803526393BEFREE
3206HOXA10C0596263Carcinogenesis0.0008241803526393BEFREE
3206HOXA10C0699791Stomach Carcinoma0.0008241803526393BEFREE
3206HOXA10C0024623Malignant neoplasm of stomach0.0008241803526393BEFREE
3206HOXA10C1140680Malignant neoplasm of ovary0.0008241803526393BEFREE
3206HOXA10C0042133Uterine Fibroids0.0008241803526393BEFREE
3206HOXA10C0006142Malignant neoplasm of breast0.0008241803526393BEFREE
3206HOXA10C0677886Epithelial ovarian cancer0.0005494535684262BEFREE
3206HOXA10C0221376Hydrosalpinx (disease)0.0005494535684262BEFREE
3206HOXA10C1153706Endometrial adenocarcinoma0.0005494535684262BEFREE
3206HOXA10C1292769Precursor B-cell lymphoblastic leukemia0.0005494535684262BEFREE
3206HOXA10C0027022Myeloproliferative disease0.0005494535684262BEFREE
3206HOXA10C1292778Chronic myeloproliferative disorder0.0005494535684262BEFREE
3206HOXA10C0027627Neoplasm Metastasis0.0005494535684262BEFREE
3206HOXA10C1709246Non-Neoplastic Disorder0.0005494535684262BEFREE
3206HOXA10C0023470Myeloid Leukemia0.0005494535684262BEFREE
3206HOXA10C0023267Fibroid Tumor0.0005494535684262BEFREE
3206HOXA10C1961099Precursor T-Cell Lymphoblastic Leukemia-Lymphoma0.0005494535684262BEFREE
3206HOXA10C0017636Glioblastoma0.0005494535684262BEFREE
3206HOXA10C1449563Cardiomyopathy, Familial Idiopathic0.0002747267842131BEFREE
3206HOXA10C2939461Myeloid neoplasm0.0002747267842131BEFREE
3206HOXA10C1698581Rokitansky Kuster Hauser syndrome0.0002747267842131BEFREE
3206HOXA10C0686619Secondary malignant neoplasm of lymph node0.0002747267842131BEFREE
3206HOXA10C1849699Progesterone Resistance0.0002747267842131BEFREE
3206HOXA10C0476089Endometrial Carcinoma0.0002747267842131BEFREE
3206HOXA10C0346429Multiple malignancy0.0002747267842131BEFREE
3206HOXA10C2347126Microscopic Polyarteritis0.0002747267842131BEFREE
3206HOXA10C0346163Endometrioid carcinoma ovary0.0002747267842131BEFREE
3206HOXA10C0039585Androgen-Insensitivity Syndrome0.0002747267842131BEFREE
3206HOXA10C0007137Squamous cell carcinoma0.0002747267842131BEFREE
3206HOXA10C0010709Cyst0.0002747267842131BEFREE
3206HOXA10C0017638Glioma0.0002747267842131BEFREE
3206HOXA10C0022876Premature Obstetric Labor0.0002747267842131BEFREE
3206HOXA10C0023449Acute lymphocytic leukemia0.0002747267842131BEFREE
3206HOXA10C0025286Meningioma0.0002747267842131BEFREE
3206HOXA10C0025500Mesothelioma0.0002747267842131BEFREE
3206HOXA10C0027086Myoma0.0002747267842131BEFREE
3206HOXA10C0032002Pituitary Diseases0.0002747267842131BEFREE
3206HOXA10C0032580Adenomatous Polyposis Coli0.0002747267842131BEFREE
3206HOXA10C0332996Persistent embryonic structure0.0002747267842131BEFREE
3206HOXA10C0043119Werner Syndrome0.0002747267842131BEFREE
3206HOXA10C0152240Uterus bilocularis0.0002747267842131BEFREE
3206HOXA10C0153381Malignant neoplasm of mouth0.0002747267842131BEFREE
3206HOXA10C0156344Endometriosis of ovary0.0002747267842131BEFREE
3206HOXA10C0156369Uterine Polyp0.0002747267842131BEFREE
3206HOXA10C0175703Thrombocytopenia-Absent Radius Syndrome0.0002747267842131BEFREE
3206HOXA10C0178874Tumor Progression0.0002747267842131BEFREE
3206HOXA10C0205834Meningiomas, Multiple0.0002747267842131BEFREE
3206HOXA10C0220641Lip and Oral Cavity Carcinoma0.0002747267842131BEFREE
3206HOXA10C0266383Uterine Anomalies0.0002747267842131BEFREE